2016
DOI: 10.1016/j.jdcr.2016.09.003
|View full text |Cite
|
Sign up to set email alerts
|

Multiple palpebral syringomas occurring after initiation of BRAF inhibition therapy in a patient with metastatic melanoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…Therefore, activation of ERK1/2 may be important in the development and progression of melanoma. Pre-clinical and clinical trial studies developed the treatment of melanoma by inhibition of this signaling pathway target including using BRAF inhibitors; the upstream of ERK1/2 [ 28 , 29 ]. Inhibition of ERK pathway in melanoma cells with BRAF inhibitors results in cell cycle arrest and promotes cell death including apoptosis.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, activation of ERK1/2 may be important in the development and progression of melanoma. Pre-clinical and clinical trial studies developed the treatment of melanoma by inhibition of this signaling pathway target including using BRAF inhibitors; the upstream of ERK1/2 [ 28 , 29 ]. Inhibition of ERK pathway in melanoma cells with BRAF inhibitors results in cell cycle arrest and promotes cell death including apoptosis.…”
Section: Discussionmentioning
confidence: 99%